BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29236149)

  • 1. Transcatheter aortic valve replacement with balloon-expandable valve : Analysis of initial experience in China.
    Shen Y; Zhang H; Zhang L; Li H; Mao H; Pei Y; Jing Z; Lu Q
    Herz; 2018 Dec; 43(8):746-751. PubMed ID: 29236149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter aortic valve implantation with balloon-expandable valve: early experience from China.
    Lu Q; Pei Y; Wu H; Wang Z; Zaiping J
    Rev Bras Cir Cardiovasc; 2015; 30(4):425-32. PubMed ID: 27163416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-in-man transfemoral transcatheter aortic valve replacement with the 29 mm Edwards SAPIEN XT valve.
    Freeman M; Rodés-Cabau J; Urena M; DeLarochelliere R; Dumont E; Masson JB; Willson AB; Binder RK; Toggweiler S; Leipsic J; Wood DA; Webb JG
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):664-70. PubMed ID: 22744829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Balloon-Expandable Transcatheter Heart Valve: A Single-Center Experience.
    Husser O; Pellegrini C; Kessler T; Burgdorf C; Thaller H; Mayr NP; Ott I; Kasel AM; Schunkert H; Kastrati A; Hengstenberg C
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1809-16. PubMed ID: 26718512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
    Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial.
    Abdel-Wahab M; Mehilli J; Frerker C; Neumann FJ; Kurz T; Tölg R; Zachow D; Guerra E; Massberg S; Schäfer U; El-Mawardy M; Richardt G;
    JAMA; 2014 Apr; 311(15):1503-14. PubMed ID: 24682026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE; Nguyen-Kim TD; Gebhard C; Erhart L; Frauenfelder T; Tanner FC; Falk V; Landmesser U; Nietlispach F; Lüscher TF; Maier W; Binder RK
    J Heart Valve Dis; 2015 Jan; 24(1):10-21. PubMed ID: 26182615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized Evaluation of the SAPIEN XT Transcatheter Heart Valve System in Patients With Aortic Stenosis Who Are Not Candidates for Surgery.
    Webb JG; Doshi D; Mack MJ; Makkar R; Smith CR; Pichard AD; Kodali S; Kapadia S; Miller DC; Babaliaros V; Thourani V; Herrmann HC; Bodenhamer M; Whisenant BK; Ramee S; Maniar H; Kereiakes D; Xu K; Jaber WA; Menon V; Tuzcu EM; Wood D; Svensson LG; Leon MB
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1797-806. PubMed ID: 26718510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balloon-expandable prostheses for transcatheter aortic valve replacement.
    Ribeiro HB; Urena M; Allende R; Amat-Santos IJ; Rodés-Cabau J
    Prog Cardiovasc Dis; 2014; 56(6):583-95. PubMed ID: 24838134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year Outcomes After Transcatheter Aortic Valve Replacement With Balloon-Expandable Versus Self-Expandable Valves: Results From the CHOICE Randomized Clinical Trial.
    Abdel-Wahab M; Neumann FJ; Mehilli J; Frerker C; Richardt D; Landt M; Jose J; Toelg R; Kuck KH; Massberg S; Robinson DR; El-Mawardy M; Richardt G;
    J Am Coll Cardiol; 2015 Aug; 66(7):791-800. PubMed ID: 26271061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Transapical transcatheter aortic valve replacement for high risk pure non-calcified aortic regurgitation: two years outcome of a multi-center study].
    Liu H; Yang Y; Lu YT; ; Zhu LM; Zhu D; Guo YQ; Wang W; Wei L; Wang CS
    Zhonghua Wai Ke Za Zhi; 2018 Dec; 56(12):910-915. PubMed ID: 30497118
    [No Abstract]   [Full Text] [Related]  

  • 15. Excellent outcomes for transcatheter aortic valve replacement within 1 year of opening a low-volume centre and consideration of requirements.
    Chevalier F; Poulin F; Lamarche Y; Viet Le VH; Gallant M; Daoust A; Heylbroeck C; Serri K; Beaulieu Y; Demers P; El-Hamamsy I; Jeanmart H; Pagé P; Schampaert E; Palisaitis D; Généreux P
    Can J Cardiol; 2014 Dec; 30(12):1576-82. PubMed ID: 25442458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Device success and 30-day clinical outcome in patients undergoing preimplant valvuloplasty in transfemoral versus omitting valvuloplasty in transapical transcatheter aortic valve replacement.
    Wong SC; Pawar S; Minutello RM; Horn EM; Skubas NJ; Devereux RB; Salemi A
    J Thorac Cardiovasc Surg; 2015 Nov; 150(5):1111-7. PubMed ID: 26277463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon-expandable transcatheter aortic valve replacement in patients with extreme aortic valve calcification.
    Abramowitz Y; Jilaihawi H; Chakravarty T; Kashif M; Matar G; Hariri B; Patel J; Nakamura M; Cheng W; Makkar RR
    Catheter Cardiovasc Interv; 2016 May; 87(6):1173-9. PubMed ID: 26527374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis.
    Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J
    Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety and efficacy of transcatheter aortic valve replacement through transcarotid approach for patients with severe aortic valve stenosis].
    Pan WZ; Zhou DX; Zhang XC; Zhang L; Wei L; Ge JB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):198-202. PubMed ID: 29562424
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of transcatheter aortic valve replacement using Venus-A valve for treating patients with severe aortic stenosis].
    Song GY; Wang MY; Wang Y; Liu XB; Feng Y; Kong XQ; Wu YJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):843-847. PubMed ID: 29081172
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.